2/2020
vol. 6
Artykuł specjalny
Limitations of cancer care in Central and South-Eastern Europe: results of the international conference organized by the Central European Cooperative Oncology Group (CECOG)
- Department of Medicine I, Medical University Vienna, Vienna, Austria
- Central European Cooperative Oncology Group (CECOG)
- Coalition of Associations in Healthcare (Koalicija udruga u zdravstvu), Croatia
- Community Health Association Romania
- University Clinic Golnik, Medical Faculty Ljubljana, Slovenia
- Medical University of Gdansk, Poland
- Clinical Division of Oncology, Department of Medicine I, Medical University Vienna, Vienna, Austria
- Fight Bladder Cancer, Oxfordshire, United Kingdom
- AstraZeneca, Baar, Switzerland
- Alivia Cancer Foundation, Poland
- AstraZeneca, Bucharest, Romania
- Merck GmbH, Switzerland
- Foundation for Patients with Rare Diseases “COCARDA”, Poland, and European Cancer Patient Coalition (ECPC)
- Karolinska Institute, Stockholm, Sweden
- Vienna Cancer Center, Vienna Hospital Association and Medical University Vienna, Vienna, Austria
J Health Inequal 2020; 6 (2): 139-152
Data publikacji online: 2020/12/30
Plik artykułu
This is an Open Access journal, all articles are distributed under the
terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC
BY-NC-SA
4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to
copy
and redistribute the material in any medium or format and to remix, transform, and build upon
the
material, provided the original work is properly cited and states its license.
